Other

Increase (decrease) in amount of unrecognized tax benefits

Vertex Pharmaceuticals Increase (decrease) in amount of unrecognized tax benefits remained flat by 0.0% to $36.48M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 61.6%, from $22.58M to $36.48M. Over 2 years (FY 2023 to FY 2025), Increase (decrease) in amount of unrecognized tax benefits shows relatively stable performance with a -3.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementIncome Statement
SectionOther
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ1 2023
Last reportedQ4 2025Feb 13, 2026

How to read this metric

An increase suggests higher tax uncertainty or aggressive tax planning, while a decrease suggests resolution of past uncertainties.

Detailed definition

This represents the net change in the total reserve for uncertain tax positions during the reporting period. It reflects...

Peer comparison

Standard disclosure under ASC 740 regarding uncertain tax positions.

Metric ID: other_unrecognized_tax_benefits_period_increase_decrease

Historical Data

3 years
 FY'23FY'24FY'25
Value$156.30M$90.30M$145.90M
YoY Change-42.2%+61.6%
Range$90.30M$156.30M
CAGR-3.4%
Avg YoY Growth+9.7%
Median YoY Growth+9.7%

Frequently Asked Questions

What is Vertex Pharmaceuticals's increase (decrease) in amount of unrecognized tax benefits?
Vertex Pharmaceuticals (VRTX) reported increase (decrease) in amount of unrecognized tax benefits of $36.48M in Q4 2025.
How has Vertex Pharmaceuticals's increase (decrease) in amount of unrecognized tax benefits changed year-over-year?
Vertex Pharmaceuticals's increase (decrease) in amount of unrecognized tax benefits increased by 61.6% year-over-year, from $22.58M to $36.48M.
What is the long-term trend for Vertex Pharmaceuticals's increase (decrease) in amount of unrecognized tax benefits?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's increase (decrease) in amount of unrecognized tax benefits has grown at a -3.4% compound annual growth rate (CAGR), from $156.30M to $145.90M.
What does increase (decrease) in amount of unrecognized tax benefits mean?
The net change in the company's reserve for uncertain tax positions.